Detalhe da pesquisa
1.
Association Between T2-related Comorbidities and Effectiveness of Biologics in Severe Asthma.
Am J Respir Crit Care Med
; 209(3): 262-272, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38016003
2.
Analysis of comorbidities and multimorbidity in adult patients in the International Severe Asthma Registry.
Ann Allergy Asthma Immunol
; 132(1): 42-53, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37640263
3.
Impact of pre-biologic impairment on meeting domain-specific biologic responder definitions in patients with severe asthma.
Ann Allergy Asthma Immunol
; 132(5): 610-622.e7, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38151100
4.
Airway inflammation and hyperresponsiveness in subjects with respiratory symptoms and normal spirometry.
Eur Respir J
; 61(3)2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36396140
5.
Inhaled anti-TSLP antibody fragment, ecleralimab, blocks responses to allergen in mild asthma.
Eur Respir J
; 61(3)2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36822634
6.
Patient and physician factors associated with symptomatic undiagnosed asthma or COPD.
Eur Respir J
; 61(2)2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36328359
7.
Can we predict who will benefit most from biologics in severe asthma? A post-hoc analysis of two phase 3 trials.
Respir Res
; 24(1): 120, 2023 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37131185
8.
Comparative effectiveness of anti-IL5 and anti-IgE biologic classes in patients with severe asthma eligible for both.
Allergy
; 78(7): 1934-1948, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36929509
9.
Efficacy of dupilumab in patients with moderate-to-severe asthma and persistent airflow obstruction.
Ann Allergy Asthma Immunol
; 130(2): 206-214.e2, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36332763
10.
Measuring skill-based health literacy in chronic airway disease patients: the development and psychometric evaluation of the Vancouver airways health literacy tool (VAHLT).
Qual Life Res
; 32(10): 2875-2886, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37428406
11.
Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes.
Am J Respir Crit Care Med
; 205(1): 17-35, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34658302
12.
Derivation and validation of the UCAP-Q case-finding questionnaire to detect undiagnosed asthma and COPD.
Eur Respir J
; 60(3)2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35332067
13.
Health literacy in asthma and chronic obstructive pulmonary disease (COPD) care: a narrative review and future directions.
Respir Res
; 23(1): 361, 2022 Dec 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-36529734
14.
16-year trends in asthma hospital admissions in Canada.
Ann Allergy Asthma Immunol
; 129(4): 475-480.e2, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35779843
15.
Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes.
Respirology
; 27(1): 14-35, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34668278
16.
Benralizumab for adolescent patients with severe, eosinophilic asthma: Safety and efficacy after 3 years of treatment.
J Allergy Clin Immunol
; 148(1): 266-271.e2, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33609624
17.
As-Needed Budesonide-Formoterol versus Maintenance Budesonide in Mild Asthma.
N Engl J Med
; 378(20): 1877-1887, 2018 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-29768147
18.
Inhaled Combined Budesonide-Formoterol as Needed in Mild Asthma.
N Engl J Med
; 378(20): 1865-1876, 2018 05 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-29768149
19.
Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma.
N Engl J Med
; 378(26): 2486-2496, 2018 06 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-29782217
20.
Patient characteristics, biomarkers and exacerbation risk in severe, uncontrolled asthma.
Eur Respir J
; 58(6)2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34112734